Mingnan Chen
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
-
- vaccines and immunoinformatics approaches 5
- Ubiquitin and proteasome pathways 4
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Ashutosh Chilkoti (4 shared papers)Jonathan R. McDaniel (4 shared papers)J. Andrew MacKay (3 shared papers)Wenge Liu (2 shared papers)Andrew J. Simnick (2 shared papers)Marlène Bouvier (3 shared papers)Peng Zhao (10 shared papers)Shuyun Dong (14 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Molecular Pharmaceutics (3 papers)Biomaterials (2 papers)Theranostics (2 papers)Trends in Immunology (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Mingnan Chen
26 papers receiving 1.2k citations
Mingnan Chen's Hit Papers
Peers
Comparison fields: 5 of 82
- Biomaterials 498
- Immunology 316
- Oncology 220
- Molecular Biology 520
- Biotechnology 59
Countries citing papers authored by Mingnan Chen
This map shows the geographic impact of Mingnan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingnan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingnan Chen more than expected).
Fields of papers citing papers by Mingnan Chen
This network shows the impact of papers produced by Mingnan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingnan Chen. The network helps show where Mingnan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingnan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection Hit paper breakdown → | 2009 | 501 |
| 2 | 2007 | 139 | |
| 3 | 2014 | 118 | |
| 4 | 2010 | 81 | |
| 5 | 2019 | 61 | |
| 6 | 2015 | 49 | |
| 7 | 2014 | 44 | |
| 8 | 2016 | 42 | |
| 9 | 2008 | 33 | |
| 10 | 2016 | 32 | |
| 11 | 2017 | 28 | |
| 12 | 2021 | 26 | |
| 13 | 2017 | 26 | |
| 14 | 2018 | 12 | |
| 15 | 2002 | 12 | |
| 16 | 2016 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2017 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2019 | 6 |
About Mingnan Chen
Mingnan Chen is a scholar working on Immunology, Molecular Biology, Oncology, Biotechnology and Biomedical Engineering, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (5 papers), vaccines and immunoinformatics approaches (5 papers), Ubiquitin and proteasome pathways (4 papers), T-cell and B-cell Immunology (4 papers), Cancer Research and Treatments (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Biomaterials (498 citations), Immunology (316 citations), Oncology (220 citations), Molecular Biology (520 citations) and Biotechnology (59 citations). Mingnan Chen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Ashutosh Chilkoti, Jonathan R. McDaniel, J. Andrew MacKay, Wenge Liu, Andrew J. Simnick, Marlène Bouvier, Peng Zhao, Shuyun Dong, Jin Zhang and Xiao He. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, Biomaterials, Theranostics and Trends in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.